Enrofloxacin 200 mg, long acting vehicle q.s.ad. 1 mL
Enroflox® 20 L.A.
Injectable Solution
Thrid-generation quinolone in long-acting vehicle
Formulation
Indications
For the treatment of infectious diseases caused by Gram-positive, Gram-negative bacteria and mycoplasma susceptible to enrofloxacine, basicaly of the respiratory tract, urinary, digestive tract, auditive conduct and skin. Bovine respiratory disease, colibacilosis, salmonellosis, neumonia, bronconeumonia, mycoplasmosis, dermatitis, mastitis-metritis-agalactia, rhinitis among others. Its vehicle provides 72 hours action.
Dosage and Administration
Cattle, sheep, goats, camelids amd swines: 1 mL/40-80 Kg, dogs and cats: 0.1 mL/4-8 Kg, subcutanoeus or intramuscular route; poultry : 0.15 mL/2 Kg intramuscular route.
Commercial Presentation
Bottle x 100 mL , Bottle x 250 mL ,
registro MAGFOR
SENASA Perú: F.03.01.N.1221
MORE VISITED PRODUCTS
ChickVit® ESe OS
Oral SolutionMicroemulsified and Ballanced Association of Vitamin E with Organic Chelated Selenium
Probiolyte® WS
Soluble PowderMulti - element Complex of Vitamins, Minerals, Electrolytes, Amino acids and Probiotics